Friday 16 October 2026
Export TLSA’s income statement to Excel — free account
Tiziana Life Sciences Ltd
TLSA Healthcare Biotechnology
Insiders bought in the last twelve months.
1.06
0.01
+0.95%
Follow TLSA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
2.89 | 0.52 | 1.08 | 0.20 | 8.79 | 6.45 | 3.64 | 1.12 | 1.02 | 0.76 |
Net Debt/EBITDA |
0.55 | (0.03) | 0.48 | (0.10) | 2.34 | 1.55 | 1.25 | 0.07 | 0.24 | 0.19 |
Debt/Assets |
5.51% | 17.31% | 8.31% | 48.60% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.08 | (0.19) | 1.11 | (0.21) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.71 | 0.86 | 0.58 | 0.73 | 0.43 | 0.93 | 1.27 | 0.89 | 0.13 | 0.70 |
Capex/Depreciation |
(4.36) | (0.08) | 0.00 | (0.02) | (0.03) | (0.16) | 0.00 | 0.00 | (0.15) | (0.09) |
Interest Coverage |
(823.25) | (884.67) | (822.25) | (109.02) | (89.83) | (155.53) | (2,083.71) | 15.72 | 19.40 | 21,132.00 |
| 1,282.91% | (963.09%) | 902.10% | 373.29% | (91.89%) | (45.18%) | (50.61%) | (140.92%) | (250.49%) | (924.32%) | |
| (97.94%) | (200.32%) | (168.97%) | (200.54%) | (71.56%) | (39.20%) | (40.89%) | (91.52%) | (101.10%) | (161.82%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (629.14%) | (258.21%) | (4,656.25%) | 0.00% |
Return on Tangible Assets |
(238.99%) | 382.62% | (1,528.71%) | 159.64% | (42.01%) | (56.91%) | (87.30%) | (2,189.48%) | (6,740.34%) | 700.53% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.16) | (0.14) | (0.07) | (0.25) | (0.12) | (0.22) | (0.19) | (0.15) | (0.01) | (0.11) |
Cash per Share |
0.13 | 0.00 | 0.08 | 0.01 | 0.68 | 0.43 | 0.18 | 0.01 | 0.03 | 0.03 |
Shareholders Equity per Share |
0.09 | (0.04) | 0.01 | (0.20) | 0.64 | 0.42 | 0.19 | 0.05 | 0.04 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.09 | (0.04) | 0.01 | (0.20) | 0.64 | 0.42 | 0.19 | 0.05 | 0.04 | 0.00 |
Free Cash Flow |
(6.97) | (7.53) | (4.60) | (6.80) | (11.34) | (21.78) | (19.61) | (15.70) | (1.54) | (12.87) |
Working Capital |
4.05 | (2.30) | 0.51 | (5.85) | 62.20 | 41.13 | 17.62 | 0.80 | 0.16 | (2.66) |
Capital Expenditures |
(0.05) | 0.00 | — | 0.00 | 0.00 | (0.02) | — | — | (0.02) | (0.02) |
Net Current Asset Value |
4.05 | (2.30) | 0.51 | (6.39) | 61.91 | 41.13 | 17.38 | 0.69 | 0.16 | (2.89) |
| Other line items | ||||||||||
Quick Ratio |
2.77 | 0.60 | 0.99 | 0.18 | 8.70 | 6.28 | 3.60 | 1.09 | 1.00 | 0.72 |
Depreciation/Fixed assets |
0.31 | 0.57 | 2.29 | 42.17 | 30.33 | 8.29 | 3.00 | 9.60 | 7.75 | 9.00 |
Cash ROIC |
(68.15%) | 421.77% | (71.93%) | 163.53% | (8.82%) | (26.10%) | (52.04%) | (233.64%) | (20.17%) | (316.79%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.16) | (0.14) | (0.07) | (0.25) | (0.12) | (0.22) | (0.19) | (0.15) | (0.01) | (0.11) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.27 | 1.46 | 1.91 | 1.09 | 2.35 | 4.38 | 5.53 | 5.90 | 4.79 | 3.86 |
Average Payables |
3.45 | 3.45 | 5.35 | 6.18 | 5.99 | 5.89 | 6.36 | 6.46 | 6.81 | 8.85 |
Average Assets |
9.98 | 4.35 | 4.70 | 4.65 | 36.52 | 59.74 | 37.65 | 19.33 | 11.73 | 11.39 |
Average Common Equity |
(0.76) | 0.91 | (0.88) | (2.50) | 28.44 | 51.83 | 30.43 | 12.55 | 4.74 | 1.99 |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
Columns are period end dates